
Cleaning Up Europe’s Vaccine Mess
Apr 2, 2021 argues that the main obstacle to matching the success of the US effort is bureaucratic, not financial.
Michel Goldman, President of the Institute for Interdisciplinary Innovation in Healthcare (I3h) and Emeritus Professor of Immunology at the Université Libre de Bruxelles, was executive director of the Innovative Medicines Initiative from 2009 to 2014.
Apr 2, 2021 argues that the main obstacle to matching the success of the US effort is bureaucratic, not financial.
Jul 10, 2020 & call for greater investment in new genetically engineered treatments to combat the coronavirus.
Apr 1, 2019 proposes targeting education programs at adolescents to empower them to become immunization advocates.
Feb 1, 2019 & apply lessons from the 2008 financial crisis to the ongoing public-health emergency in the US.